Hyperbaric oxygen therapy as an alternative to surgery for non-healing pharyngocutaneous fistula

Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3857-3861. doi: 10.1007/s00405-016-4002-9. Epub 2016 Mar 26.

Abstract

The aim of the study is to examine the utilization of hyperbaric oxygen treatment (HBOT) as an alternative to surgical treatment for non-healing postoperative phayngocutaneous fistula (POPCF). A retrospective study was conducted between 2012 and 2014 of referred patients who had failed conservative treatment for POPCF at other medical centers. Reevaluation at our department was followed by therapeutic management including daily HBOT. Eight male patients with a mean age of 62.3 years were included. The average period of conservative treatment was 1 month before admittance to our department. All patients were managed with HBOT and local debridement. Closure of the POPCF was proved by a barium swallow test in seven patients (87.5 %). HBOT is recommended for patients who have failed conservative treatment for POPCF post-laryngectomy, due to a high rate of successful (87.5 %) closure and should be considered as an alternative to surgical treatment.

Keywords: Deglutition; Deglutition disorders; Hyperbaric oxygen therapy; Pharyngocutaneous fistula; Surgery; Treatment.

MeSH terms

  • Aged
  • Cutaneous Fistula / etiology
  • Cutaneous Fistula / therapy*
  • Fistula / etiology
  • Fistula / therapy*
  • Humans
  • Hyperbaric Oxygenation*
  • Laryngectomy / adverse effects
  • Male
  • Middle Aged
  • Pharyngeal Diseases / etiology
  • Pharyngeal Diseases / therapy*
  • Postoperative Complications
  • Retrospective Studies